Schedule 13G ownership disclosure
Intec Pharma Ltd.
Security class unavailable · CUSIP: M53644106
Event date: 2017-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,724,283
- Percent of class
- 10.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-18-002024
- Form type
- SC 13G
- Filer
- ACUTA CAPITAL PARTNERS, LLC
- CIK
- CIK 1582844
- Filed
- Feb 14, 2018
- Reporting period
- Dec 31, 2017
- Description
- Schedule 13G beneficial ownership